James Abbruzzese, MD

Professor of Medicine
D. C. I. Professor of Medical Oncology
Chief, Division of Medical Oncology
Member of the Duke Cancer Institute
Campus mail 440 Mudd Building, Box 3406, Durham, NC 27710
Email address james.abbruzzese@duke.edu

My research interests include the clinical study and treatment of pancreatic cancer.

In Their Words

Education and Training

  • Resident, Internal Medicine, Johns Hopkins University School of Medicine, 1979 - 1981
  • Intern, Internal Medicine, Johns Hopkins University School of Medicine, 1978 - 1979
  • M.D., University of Chicago, 1978

Publications

Chang, David Z., Ying Ma, Baoan Ji, Yan Liu, Patrick Hwu, James L. Abbruzzese, Craig Logsdon, and Huamin Wang. “Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression..” J Hematol Oncol 5 (April 4, 2012). https://doi.org/10.1186/1756-8722-5-15.

PMID
22475564
Full Text

Chatterjee, Deyali, Asif Rashid, Hua Wang, Matthew H. Katz, Robert A. Wolff, Gauri R. Varadhachary, Jeffrey E. Lee, et al. “Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy..” Am J Surg Pathol 36, no. 4 (April 2012): 552–59. https://doi.org/10.1097/PAS.0b013e318240c1c0.

PMID
22301496
Full Text

Dong, Xiaoqun, Yanan Li, Hongwei Tang, Ping Chang, Kenneth R. Hess, James L. Abbruzzese, and Donghui Li. “Insulin-like growth factor axis gene polymorphisms modify risk of pancreatic cancer..” Cancer Epidemiol 36, no. 2 (April 2012): 206–11. https://doi.org/10.1016/j.canep.2011.05.013.

PMID
21852217
Full Text

Chatterjee, Deyali, Matthew H. Katz, Asif Rashid, Hua Wang, Alina C. Iuga, Gauri R. Varadhachary, Robert A. Wolff, et al. “Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma..” Am J Surg Pathol 36, no. 3 (March 2012): 409–17. https://doi.org/10.1097/PAS.0b013e31824104c5.

PMID
22301497
Full Text

Dakik, Hassan K., Daniel J. Moskovic, Peter J. Carlson, Eric P. Tamm, Wei Qiao, Robert A. Wolff, James L. Abbruzzese, and David R. Fogelman. “The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis..” Cancer Chemotherapy and Pharmacology 69, no. 2 (February 2012): 425–30. https://doi.org/10.1007/s00280-011-1705-x.

PMID
21850466
Full Text

Hammond-Thelin, Lisa A., Melanie B. Thomas, Michiko Iwasaki, James L. Abbruzzese, Yvonne Lassere, Christina A. Meyers, Paulo Hoff, et al. “Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies..” Invest New Drugs 30, no. 1 (February 2012): 316–26. https://doi.org/10.1007/s10637-010-9535-y.

PMID
20839029
Full Text

Kaseb, Ahmed O., E. Garrett-Mayer, J. S. Morris, L. Xiao, E. Lin, G. Onicescu, M. M. Hassan, et al. “Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial..” Oncology 82, no. 2 (2012): 67–74. https://doi.org/10.1159/000335963.

PMID
22327795
Full Text

Estrella, Jeannelyn S., Asif Rashid, Jason B. Fleming, Matthew H. Katz, Jeffrey E. Lee, Robert A. Wolf, Gauri R. Varadhachary, et al. “Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation..” Cancer 118, no. 1 (January 1, 2012): 268–77. https://doi.org/10.1002/cncr.26243.

PMID
21735446
Full Text

Zhao, Qing, Asif Rashid, Yun Gong, Matthew H. Katz, Jeffrey E. Lee, Robert Wolf, Aparna Balachandran, et al. “Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis..” Ann Diagn Pathol 16, no. 1 (January 2012): 29–37. https://doi.org/10.1016/j.anndiagpath.2011.08.005.

PMID
22050964
Full Text

Pages